QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 176 filers reported holding QIAGEN NV in Q1 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $205,000 | +1.5% | 7,328 | -0.4% | 0.00% | 0.0% |
Q3 2016 | $202,000 | +26.2% | 7,356 | +0.4% | 0.00% | +100.0% |
Q2 2016 | $160,000 | -3.6% | 7,325 | -1.6% | 0.00% | 0.0% |
Q1 2016 | $166,000 | -19.4% | 7,447 | -0.2% | 0.00% | -50.0% |
Q4 2015 | $206,000 | +7.9% | 7,459 | +0.9% | 0.00% | 0.0% |
Q3 2015 | $191,000 | +3.2% | 7,394 | -1.1% | 0.00% | 0.0% |
Q2 2015 | $185,000 | -4.1% | 7,473 | -2.4% | 0.00% | 0.0% |
Q1 2015 | $193,000 | +10.3% | 7,655 | +2.5% | 0.00% | +100.0% |
Q4 2014 | $175,000 | +1.2% | 7,467 | -1.7% | 0.00% | 0.0% |
Q3 2014 | $173,000 | -7.5% | 7,595 | -0.9% | 0.00% | -50.0% |
Q2 2014 | $187,000 | +14.0% | 7,667 | -1.5% | 0.00% | +100.0% |
Q1 2014 | $164,000 | -11.8% | 7,780 | -0.4% | 0.00% | -50.0% |
Q4 2013 | $186,000 | +13.4% | 7,810 | +1.7% | 0.00% | 0.0% |
Q3 2013 | $164,000 | +5.1% | 7,676 | -1.8% | 0.00% | +100.0% |
Q2 2013 | $156,000 | – | 7,814 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |